Modifying the American Society for Therapeutic Radiology and Oncology definition of biochemical failure to minimize the influence of backdating in patients with prostate cancer treated with 3-dimensional conformal radiation therapy alone

Journal of Urology

Volumn 169, Issue 6, 2003, Pages 2153-2159

  Horwitz, Eric M ^a   Uzzo, Robert G ^b   Hanlon, Alexandra L ^b   Greenberg, Richard E ^b   Hanks, Gerald E ^b   Pollack, Alan ^b  

^a FOX CHASE CANCER CENTER   (United States)

^b NONE

Author keywords

Prostate; Prostate specific antigen; Prostatic neoplasms; Radiotherapy; Treatment failure

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; EVALUATION; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA; RADIATION DOSE; STANDARD; TREATMENT FAILURE;

EID: 0038287404     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000067181.52741.09     Document Type: Article

References (23)

1. Consensus statement: Guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys, 37: 1035, 1997
2. Gretzer, M. B., Trock, B. J., Han, M. and Walsh, P. C.: A critical analysis of the interpretation of biochemical failure in surgically treated patients using the American Society for Therapeutic Radiation and Oncology criteria. J Urol, 168: 1419, 2002
3. Amling, C. L., Bergstralh, E. J., Blute, M. L., Slezak, J. M. and Zincke, H.: Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point? J Urol, 165: 1146, 2001
4. Critz, F. A.: A standard definition of disease freedom is needed for prostate cancer: undetectable prostate specific antigen compared with the American Society of Therapeutic Radiology and Oncology consensus definition. J Urol, 167: 1310, 2002
5. Horwitz, E. M., Vicini, F. A., Ziaja, E. L., Gonzalez, J., Dmuchowski, C. F., Stromberg, J. S. et al: Assessing the variability of outcome for patients treated with localized prostate irradiation using different definitions of biochemical control. Int J Radiat Oncol Biol Phys, 36: 565, 1996
6. McLaughlin, P. W., Sandler, H. M. and Jiroutek, M. R.: Prostatespecific antigen following prostate radiotherapy: how low can you go? J Clin Oncol, 14: 2889, 1996
7. American Joint Committee on Cancer: Prostate. In: AJCC Cancer Staging Manual. Edited by F. L. Greene, D. L. Page, I. D. Fleming et al. Philadelphia: Lippincott Raven Publishers, pp. 309-316, 2002
8. Horwitz, E. M., Hanlon, A. L., Pinover, W. H., Anderson, P. R. and Hanks, G. E.: Defining the optimal radiation dose with three-dimensional conformal radiation therapy for patients with nonmetastatic prostate carcinoma by using recursive partitioning techniques. Cancer, 92: 1281, 2001
9. Kaplan, E. L. and Meier, P.: Nonparametric estimation from incomplete observations. J Am Stat Assoc, 53: 457, 1958
10. Lee, E. T.: Statistical Methods for Survival Data Analysis. Belmont, California: Lifetime Learning Publications, p. 557, 1980
11. Hanks, G. E., Corn, B. W., Lee, W. R., Hunt, M., Hanlon, A. and Schultheiss, T. E.: External beam irradiation of prostate cancer. Conformal treatment techniques and outcomes for the 1990s. Cancer, 75: 1972, 1995
12. Kaplan, I. D., Cox, R. S. and Bagshaw, M. A.: Prostate specific antigen after external beam radiotherapy for prostatic cancer: followup. J Urol, 149: 519, 1993
13. Zietman, A. L., Coen, J. J., Dallow, K. C. and Shipley, W. U.: The treatment of prostate cancer by conventional radiation therapy: an analysis of long-term outcome. Int J Radiat Oncol Biol Phys, 32: 287, 1995
14. Horwitz, E. M., Vicini, F. A., Ziaja, E. L., Dmuchowski, C. F., Stromberg, J. S. and Martinez, A. A.: The correlation between the ASTRO consensus panel definition of biochemical failure and clinical outcome for patients with prostate cancer treated with external beam irradiation. American Society of Therapeutic Radiology and Oncology. Int J Radiat Oncol Biol Phys, 41: 267, 1998
15. Ennis, R. D., Malyszko, B. K., Heitjan, D. F., Rubin, M. A., O'Toole, K. M. and Schiff, P. B.: Changes in biochemical disease-free survival rates as a result of adoption of the consensus conference definition in patients with clinically localized prostate cancer treated with external-beam radiotherapy. Int J Radiat Oncol Biol Phys, 41: 511, 1998
16. Hanlon, A. L. and Hanks, G. E.: Scrutiny of the ASTRO consensus definition of biochemical failure in irradiated prostate cancer patients demonstrates its usefulness and robustness. American Society for Therapeutic Radiology and Oncology. Int J Radiat Oncol Biol Phys, 46: 559, 2000
17. Vicini, F. A., Kestin, L. L. and Martinez, A. A.: The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancer. Int J Radiat Oncol Biol Phys, 45: 553, 1999
18. Hanlon, A. L., Pinover, W. H., Horwitz, E. M. and Hanks, G. E.: Regarding Vicini et al., IJROBP 1999, 45:553-561. Int J Radiat Oncol Biol Phys, 47: 1457, 2000
19. Connell, P. P., Ignacio, L., McBride, R. B., Weichselbaum, R. R. and Vijayakumar, S.: Caution in interpreting biochemical control rates after treatment of prostate cancer: length of follow-up influences results. Urology, 54: 875, 1999
20. Catalona, W. J. and Smith, D. S.: 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol, 152: 1837, 1994
21. Ramos, C. G., Carvalhal, G. F., Smith, D. S., Mager, D. E. and Catalona, W. J.: Clinical and pathological characteristics, and recurrence rates of stage T1C versus T2A or T2B prostate cancer. J Urol, 161: 1525, 1999
22. Kupelian, P. A., Elshaikh, M., Reddy, C. A., Zippe, C. and Klein, E. A.: Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy. J Clin Oncol, 20: 3376, 2002
23. Kattan, M. W., Fearn, P. A., Leibel, S. and Potters, L.: The definition of biochemical failure in patients treated with definitive radiotherapy. Int J Radiat Oncol Biol Phys, 48: 1469, 2000